CXCR3 and inflammatory bowel disease: Indeed, CXCR3 antagonism has been associated with inflammatory and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus, chronic obstructive pulmonary disease, psoriasis, organ transplant rejection and graft-vs-host disease, asthma, and type 1 diabetes50.